150 related articles for article (PubMed ID: 31784083)
1. IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ.
Li J; Zeng M; Yan K; Yang Y; Li H; Xu X
Biochem Biophys Res Commun; 2020 Feb; 522(2):525-531. PubMed ID: 31784083
[TBL] [Abstract][Full Text] [Related]
2. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-κB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
Liu J; Wu Z; Han D; Wei C; Liang Y; Jiang T; Chen L; Sha M; Cao Y; Huang F; Geng X; Yu J; Shen Y; Wang H; Feng L; Wang D; Fang S; Wang S; Shen Y
Hepatology; 2020 Apr; 71(4):1262-1278. PubMed ID: 31469428
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin-17 promotes mouse hepatoma cell proliferation by antagonizing interferon-γ].
Li J; Yan K; Yang Y; Li H; Wang Z; Xu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):1-5. PubMed ID: 30692059
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
Xu P; Sun Z; Wang Y; Miao C
Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
Wang H; Wang J; Shi X; Ding Y
J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
[TBL] [Abstract][Full Text] [Related]
6. IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB.
Gao Q; Liu Y; Wu Y; Zhao Q; Wang L; Gao S; Wen W; Zhang W; Guo N; Zhou J; Yuan Z
Int J Mol Med; 2016 Feb; 37(2):347-58. PubMed ID: 26677135
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
[TBL] [Abstract][Full Text] [Related]
9. Tumor Suppressor p14ARF Enhances IFN-γ-Activated Immune Response by Inhibiting PIAS1 via SUMOylation.
Alagu J; Itahana Y; Sim F; Chao SH; Bi X; Itahana K
J Immunol; 2018 Jul; 201(2):451-464. PubMed ID: 29848755
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β.
de Paus RA; van Wengen A; Schmidt I; Visser M; Verdegaal EM; van Dissel JT; van de Vosse E
Cytokine; 2013 Feb; 61(2):645-55. PubMed ID: 23299081
[TBL] [Abstract][Full Text] [Related]
12. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
[TBL] [Abstract][Full Text] [Related]
13. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
[TBL] [Abstract][Full Text] [Related]
14. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.
Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP
World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094
[TBL] [Abstract][Full Text] [Related]
15. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
[TBL] [Abstract][Full Text] [Related]
16. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta suppresses IFN-gamma-STAT1-dependent gene transcription by enhancing STAT1-PIAS1 interactions in epithelia but not monocytes/macrophages.
Reardon C; McKay DM
J Immunol; 2007 Apr; 178(7):4284-95. PubMed ID: 17371985
[TBL] [Abstract][Full Text] [Related]
19. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.
Yin L; Fang Z; Shen NJ; Qiu YH; Li AJ; Zhang YJ
Drug Des Devel Ther; 2017; 11():2841-2850. PubMed ID: 29033545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
